Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 07, 2019

SELL
$55.63 - $73.24 $5.5 Million - $7.24 Million
-98,785 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$52.05 - $66.51 $1.77 Million - $2.27 Million
34,100 Added 52.72%
98,785 $6.5 Million
Q2 2018

Aug 07, 2018

SELL
$48.33 - $55.64 $42,047 - $48,406
-870 Reduced 1.33%
64,685 $3.27 Million
Q1 2018

Apr 30, 2018

BUY
$44.44 - $54.39 $2.91 Million - $3.57 Million
65,555 New
65,555 $3.45 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $473M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.